Rate My Professor Kamal Sud

Professor Sud's research specializations encompass nephrology, with a focus on peritoneal dialysis outcomes, peritonitis management, technique failure, acute kidney injury, and home dialysis strategies. He has authored over 200 peer-reviewed publications, including highly cited works such as 'A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy' (2007, 488 citations), 'End-stage renal disease in India and Pakistan: burden of disease and management issues' (2003, 289 citations), and recent contributions like 'Hospital-acquired peritonitis in patients on peritoneal dialysis: A call to action' (2023) and 'Hybrid dialysis: Two modalities twice the benefit?' (2025). He contributes editorially as a subject editor for two international journals and holds leadership roles in global nephrology organizations, including the Executive Council of the Asian Pacific Society of Nephrology as ANZSN representative, International Society for Peritoneal Dialysis committees on Nominations, Scholarships and Awards, and Standards & Guidelines, ISN CME Program Committee, and the Joint ISN-ISPD International Home Dialysis Consortium. Professor Sud is a Fellow of the American Society of Nephrology (FASN).